Balancing the cardiometabolic benefits and risks of statins

    Research output: Contribution to journalComment/debate

    9 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)541-543
    Number of pages3
    JournalThe Lancet
    Volume380
    Issue number9841
    DOIs
    Publication statusPublished - 11 Aug 2012

    Cite this

    @article{77c679fd0bb0449a973b4fe744f1791a,
    title = "Balancing the cardiometabolic benefits and risks of statins",
    keywords = "Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Fluorobenzenes, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Male, Pyrimidines, Rosuvastatin Calcium, Sulfonamides, Comment, Journal Article",
    author = "Watts, {Gerald F} and Ooi, {Esther M}",
    year = "2012",
    month = "8",
    day = "11",
    doi = "10.1016/S0140-6736(12)61301-4",
    language = "English",
    volume = "380",
    pages = "541--543",
    journal = "Lancet",
    issn = "0140-6736",
    publisher = "Academic Press",
    number = "9841",

    }

    Balancing the cardiometabolic benefits and risks of statins. / Watts, Gerald F; Ooi, Esther M.

    In: The Lancet, Vol. 380, No. 9841, 11.08.2012, p. 541-543.

    Research output: Contribution to journalComment/debate

    TY - JOUR

    T1 - Balancing the cardiometabolic benefits and risks of statins

    AU - Watts, Gerald F

    AU - Ooi, Esther M

    PY - 2012/8/11

    Y1 - 2012/8/11

    KW - Cardiovascular Diseases

    KW - Diabetes Mellitus, Type 2

    KW - Female

    KW - Fluorobenzenes

    KW - Humans

    KW - Hydroxymethylglutaryl-CoA Reductase Inhibitors

    KW - Male

    KW - Pyrimidines

    KW - Rosuvastatin Calcium

    KW - Sulfonamides

    KW - Comment

    KW - Journal Article

    U2 - 10.1016/S0140-6736(12)61301-4

    DO - 10.1016/S0140-6736(12)61301-4

    M3 - Comment/debate

    VL - 380

    SP - 541

    EP - 543

    JO - Lancet

    JF - Lancet

    SN - 0140-6736

    IS - 9841

    ER -